15
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Phytochemistry and pharmacological activity of the genus artemisia

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Artemisia and its allied species have been employed for conventional medicine in the Northern temperate regions of North America, Europe, and Asia for the treatments of digestive problems, morning sickness, irregular menstrual cycle, typhoid, epilepsy, renal problems, bronchitis malaria, etc. The multidisciplinary use of artemisia species has various other health benefits that are related to its traditional and modern pharmaceutical perspectives. The main objective of this review is to evaluate the traditional, modern, biological as well as pharmacological use of the essential oil and herbal extracts of  Artemisia nilagirica, Artemisia parviflora, and other allied species of Artemisia. It also discusses the botanical circulation and its phytochemical constituents viz disaccharides, polysaccharides, glycosides, saponins, terpenoids, flavonoids, and carotenoids. The plants have different biological importance like antiparasitic, antimalarial, antihyperlipidemic, antiasthmatic, antiepileptic, antitubercular, antihypertensive, antidiabetic, anxiolytic, antiemetic, antidepressant, anticancer, hepatoprotective, gastroprotective, insecticidal, antiviral activities, and also against COVID-19. Toxicological studies showed that the plants at a low dose and short duration are non or low-toxic. In contrast, a high dose at 3 g/kg and for a longer duration can cause toxicity like rapid respiration, neurotoxicity, reproductive toxicity , etc. However, further in-depth studies are needed to determine the medicinal uses, clinical efficacy and safety are crucial next steps.

          Related collections

          Most cited references373

          • Record: found
          • Abstract: found
          • Article: not found

          Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

          Summary Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62–71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05–0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Antioxidant Determinations by the Use of a Stable Free Radical

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The global distribution of clinical episodes of Plasmodium falciparum malaria.

              Interest in mapping the global distribution of malaria is motivated by a need to define populations at risk for appropriate resource allocation and to provide a robust framework for evaluating its global economic impact. Comparison of older and more recent malaria maps shows how the disease has been geographically restricted, but it remains entrenched in poor areas of the world with climates suitable for transmission. Here we provide an empirical approach to estimating the number of clinical events caused by Plasmodium falciparum worldwide, by using a combination of epidemiological, geographical and demographic data. We estimate that there were 515 (range 300-660) million episodes of clinical P. falciparum malaria in 2002. These global estimates are up to 50% higher than those reported by the World Health Organization (WHO) and 200% higher for areas outside Africa, reflecting the WHO's reliance upon passive national reporting for these countries. Without an informed understanding of the cartography of malaria risk, the global extent of clinical disease caused by P. falciparum will continue to be underestimated.
                Bookmark

                Author and article information

                Contributors
                dheeraj.bisht729@gmail.com
                Journal
                Arch Pharm Res
                Arch Pharm Res
                Archives of Pharmacal Research
                Pharmaceutical Society of Korea (Seoul )
                0253-6269
                1976-3786
                24 April 2021
                : 1-36
                Affiliations
                [1 ]GRID grid.411155.5, ISNI 0000 0001 1533 858X, Department of Pharmaceutical Sciences, Sir J. C. Bose Technical Campus Bhimtal, , Kumaun University, ; Nainital, Uttarakhand 263136 India
                [2 ]GRID grid.430140.2, ISNI 0000 0004 1799 5083, School of Pharmaceutical Sciences, , Shoolini University, ; Solan, H.P. 173 229 India
                [3 ]GRID grid.444472.5, ISNI 0000 0004 1756 3061, Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, , UCSI University, ; 56000 Kuala Lumpur, Malaysia
                [4 ]GRID grid.464870.9, Laureate Institute of Pharmacy, ; Distt. Kangra, Kathog, H.P. 176031 India
                [5 ]GRID grid.117476.2, ISNI 0000 0004 1936 7611, Discipline of Pharmacy, Graduate School of Health, , University of Technology, ; Sydney, 2007 Australia
                [6 ]GRID grid.411729.8, ISNI 0000 0000 8946 5787, Department of Life Sciences, School of Pharmacy, , International Medical University (IMU), ; Bukit Jalil, 57000 Kuala Lumpur, Malaysia
                Article
                1328
                10.1007/s12272-021-01328-4
                8067791
                33893998
                03d8d367-47ae-4e25-9a14-15f521bc1472
                © The Pharmaceutical Society of Korea 2021

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 1 July 2020
                : 26 March 2021
                Categories
                Review

                artemisia,phytochemical constituents,essential oil,sesquiterpenes,pharmacological activity,covid-19,toxicological studies

                Comments

                Comment on this article